Skip to main content

Table 4 Outcomes of DPP-4i use, N = 105

From: Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital

ParametersPre DPP-4i usePost DPP-4i useMean difference (95% CI)p value£
HbA1c (%)8.5 ± 1.87.6 ± 1.7− 0.90 (− 1.22, − 0.58)< 0.0001*
FBG (mmol/L)9.2 ± 3.88.0 ± 3.2−1.15 (− 1.80, − 0.51)0.001*
Weight (kg)78.1 ± 14.578.1 ± 14.40.08 (− 0.41,0.57)0.745
BMI (kg/m2)29.5 ± 4.630.0 ± 7.00.50 (− 0.51,1.51)0.332
  1. £Paired T-test conducted. p value is significant at< 0.05
  2. Values reported as mean ± SD.